103
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Synthesis and MDR inhibitory activity evaluation of derivatives of schizandrin A

, , , , &
Pages 549-556 | Received 28 Dec 2009, Accepted 07 Apr 2010, Published online: 13 Jul 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Shi-Yi Xu, Hui Su, Xing-Yu Zhu, Xue-Ying Li, Jie Li, Xi Chen, Qi Wang, Ruo-Yi Hao & Xue-Ying Yan. (2022) Long-circulating doxorubicin and schizandrin A liposome with drug-resistant liver cancer activity: preparation, characterization, and pharmacokinetic. Journal of Liposome Research 32:2, pages 107-118.
Read now

Articles from other publishers (2)

Tiantian Wang, Yu Zhou, Hao Zheng, Tao Shen, Dongmei Wang & Jinlan Zhang. (2023) Chemoproteomics identifies Ykt6 as the direct target of schisandrin A for neuroprotection. Chinese Chemical Letters 34:6, pages 107887.
Crossref
Xiaobo Tang, Xiaoke Gu, Zhiguang Ren, Yuanfang Ma, Yisheng Lai, Hui Peng, Sixun Peng & Yihua Zhang. (2012) Synthesis and evaluation of substituted dibenzo[c,e]azepine-5-ones as P-glycoprotein-mediated multidrug resistance reversal agents. Bioorganic & Medicinal Chemistry Letters 22:8, pages 2675-2680.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.